Ebola

Human trials start on Ebola vaccine

Published in Vaccine Weekly, December 10th, 2003

A volunteer has received the first human inoculation of an experimental vaccine designed to prevent infection by Ebola, a highly lethal African virus that some officials fear could be used as a weapon of bioterrorism.

Researchers at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, one of the U.S. National Institutes of Health (NIH), administered the vaccine to a volunteer at the NIH clinical center in Bethesda, Maryland, officials announced.

The first human trial comes just 3 years after researchers from the vaccine center announced that an experimental Ebola vaccine had protected monkeys fully from the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2003-12-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry